These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7908864)

  • 1. Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man.
    Wheeldon NM; McDevitt DG; McFarlane LC; Lipworth BJ
    Clin Sci (Lond); 1994 Mar; 86(3):331-7. PubMed ID: 7908864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.
    Wheeldon NM; McDevitt DG; Lipworth BJ
    Br J Clin Pharmacol; 1994 Apr; 37(4):363-9. PubMed ID: 7912539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor subtypes mediating the airways response to BRL 35135 in man.
    Newnham DM; Ingram CG; Mackie A; Lipworth BJ
    Br J Clin Pharmacol; 1993 Dec; 36(6):567-71. PubMed ID: 12959274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do beta 3-adrenoceptors mediate metabolic responses to isoprenaline.
    Wheeldon NM; McDevitt DG; Lipworth BJ
    Q J Med; 1993 Sep; 86(9):595-600. PubMed ID: 8255974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans.
    Liu YL; Toubro S; Astrup A; Stock MJ
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):678-85. PubMed ID: 8574280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of salbutamol and BRL 37344 on diastolic arterial blood pressure, plasma glucose and plasma lactate in rabbits.
    Reverte M; Moratinos J
    Fundam Clin Pharmacol; 1994; 8(5):417-24. PubMed ID: 7875635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist.
    Irie Y; Igawa T; Hosokawa T; Saitoh Y
    Eur J Pharmacol; 1979 Feb; 53(4):351-8. PubMed ID: 33812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an atypical, or beta 3-adrenoceptor in ferret tracheal epithelium.
    Webber SE; Stock MJ
    Br J Pharmacol; 1992 Apr; 105(4):857-62. PubMed ID: 1354537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two beta 3-adrenoceptor agonists, SR 58611A and BRL 37344, and of salbutamol on cholinergic and NANC neural contraction in guinea-pig main bronchi in vitro.
    Martin CA; Naline E; Manara L; Advenier C
    Br J Pharmacol; 1993 Dec; 110(4):1311-6. PubMed ID: 7905768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the beta 3-adrenoceptor agonist BRL 37344 on lipomobilization and plasma glucose levels in conscious fasted rabbits.
    Reverte M; Rivas-Cabañero L
    Can J Physiol Pharmacol; 1996 Mar; 74(3):251-6. PubMed ID: 8773403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation.
    Liu YL; Stock MJ
    Br J Pharmacol; 1995 Feb; 114(4):888-94. PubMed ID: 7773551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.
    Santti E; Huupponen R; Rouru J; Hänninen V; Pesonen U; Jhanwar-Uniyal M; Koulu M
    Br J Pharmacol; 1994 Dec; 113(4):1231-6. PubMed ID: 7889277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat.
    Bahl AK; Clayton NM; Coates J; Martin DP; Oakley IG; Strong P; Trevethick MA
    Br J Pharmacol; 1996 Feb; 117(3):580-586. PubMed ID: 8821552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 2001 Jun; 51(6):583-9. PubMed ID: 11422018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lower than conventional doses of oral nadolol on relative beta 1/beta 2-adrenoceptor blockade.
    Wheeldon NM; McDevitt DG; Lipworth BJ
    Br J Clin Pharmacol; 1994 Aug; 38(2):103-8. PubMed ID: 7981009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some metabolic and hormonal effects of salbutamol in man.
    Massara F; Fassio V; Camanni F; Martina V; Molinatti G
    Acta Diabetol Lat; 1976; 13(3-4):146-53. PubMed ID: 1020612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway and metabolic resistance to intravenous salbutamol: a study in normal man.
    Holgate ST; Stubbs WA; Wood PJ; McCaughey ES; Alberti KG; Tattersfield AE
    Clin Sci (Lond); 1980 Sep; 59(3):155-61. PubMed ID: 7000415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.
    Liu YL; Cawthorne MA; Stock MJ
    Br J Pharmacol; 1996 Mar; 117(6):1355-61. PubMed ID: 8882636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.